Co-Diagnostics, Inc. - 8-K Filing

Co-Diagnostics amends equity distribution agreement with Maxim Group, removing aggregate sales cap (Items: 1.01 Entry into a Material Definitive Agreement As previously disclosed, on October 20, 2025, Co-Diagnostics, Inc, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $CODX

Read the full article at SEC EDGAR

More Regulatory news